Clinical trial
A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine…
NCT00002207 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002207 |
|---|---|
| Title | A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients |
| Official title | A Randomized, Double-Blind Study of the Antiviral Activity of Once-Daily and Twice-Daily Dosing of Didanosine in Combination With Twice-Daily Dosing of Stavudine in HIV-Infected Subjects |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Stavudine, Didanosine |
| Start date | Feb 1, 2004 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Aug 31, 2001 |
| Last update posted | Apr 25, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: